NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis. (Q43726776)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Foletti A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Paroz C

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Rüegg C

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

1041-1047

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm0901-1041

10 November 2019

exact match

0 references

cites work

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (part I)

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Identification of a phorbol ester-repressible v-src-inducible gene

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Prevention of alphaII(b)beta3 activation by non-steroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Pharmacological analysis of cyclooxygenase-1 in inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Ligand binding to integrin alpha(v)beta(3) requires tyrosine 178 in the alpha(v) subunit

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Activation of Rac and Cdc42 by integrins mediates cell spreading

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

The small GTP-binding protein rac regulates growth factor-induced membrane ruffling

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Role of BAX in the apoptotic response to anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Sulindac inhibits activation of the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Elevated cyclooxygenase-2 levels in Min mouse adenomas

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

1 reference

https://api.crossref.org/works/10.1038%2FNM0901-1041

7 January 2021

Identifiers

DOI

10.1038/NM0901-1041

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11533708%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference